Longevity Health Holdings Inc. 2026年季度报告

(Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 LONGEVITY HEALTH HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware(State or other jurisdiction ofincorporation or organization)2403 Sidney Street, Suite 300Pittsburgh, Pennsylvania Registrant’s telephone number, including area code: Securities registered pursuant to Section 12(b) of the Act: None Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging Large accelerated filerNon-accelerated filerEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). As of May 13, 2026, the registrant had 2,475,321 shares of common stock, $0.0001 par value per share, outstanding. Table of Contents PART I.FINANCIAL INFORMATION Item 1.Unaudited Condensed Consolidated Financial StatementsCondensed Consolidated Balance Sheets Condensed Consolidated Statements of OperationsCondensed Consolidated Statements of Stockholders’ Deficit Condensed Consolidated Statements of Cash FlowsNotes to Unaudited Condensed Consolidated Financial StatementsItem 2.Management’s Discussion and Analysis of Financial Condition and Results of OperationsItem 3.Quantitative and Qualitative Disclosures About Market RiskItem 4.Controls and Procedures PART II.OTHER INFORMATION Item 1.Legal ProceedingsItem 1A.Risk FactorsItem 2.Unregistered Sales of Equity Securities and Use of ProceedsItem 3.Defaults Upon Senior SecuritiesItem 4.Mine Safety DisclosuresItem 5.Other InformationItem 6.Exhibits Signatures LONGEVITY HEALTH HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICITThree Months Ended March 31, 2026 and 2025 LONGEVITY HEALTH HOLDINGS, INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS Unless the context requires otherwise, references to the “Company” are intended to refer to Longevity Health Holdings, Inc., aDelaware corporation, and its consolidated subsidiaries. The Company is a bio-aesthetics company focused on longevity andhealthy aging. The Company’s cosmetic skincare and haircare products support skin and hair health and are tailored to meet thedemanding technical requirements of professional care providers and discerning retail consumers. The Company primarily sells its Risks and Uncertainties Economic uncertainty in global markets, driven by geopolitical tensions, including ongoing conflicts in Europe and the MiddleEast, trade disputes, economic sanctions, and tariffs, has contributed to volatility in commodity prices, supply chain disruptions,inflationary pressures, and fluctuating interest rates. These conditions could materially and adversely affect the Company's NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generallyaccepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 ofRegulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financialstatements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the“Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage ofcertain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growthcompanies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Further, S